Hsbc Holdings PLC Has $33,000 Stake in Cronos Group Inc. (NASDAQ:CRON)

Hsbc Holdings PLC decreased its stake in shares of Cronos Group Inc. (NASDAQ:CRON – Get Rating) by 53.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,457 shares of the company’s stock after selling 13,380 shares during the quarter. Hsbc Holdings PLC’s holdings in Cronos Group were worth $33,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Creative Planning grew its position in shares of Cronos Group by 23.1% during the 2nd quarter. Creative Planning now owns 16,549 shares of the company’s stock worth $47,000 after buying an additional 3,100 shares during the period. Mackenzie Financial Corp grew its position in shares of Cronos Group by 5.7% during the 3rd quarter. Mackenzie Financial Corp now owns 82,484 shares of the company’s stock worth $231,000 after buying an additional 4,467 shares during the period. Credit Suisse AG lifted its holdings in shares of Cronos Group by 3.0% in the 3rd quarter. Credit Suisse AG now owns 173,719 shares of the company’s stock worth $490,000 after purchasing an additional 5,052 shares in the last quarter. UBS Group AG lifted its holdings in shares of Cronos Group by 22.0% in the 3rd quarter. UBS Group AG now owns 28,433 shares of the company’s stock worth $80,000 after purchasing an additional 5,123 shares in the last quarter. Finally, Cetera Advisors LLC lifted its holdings in shares of Cronos Group by 53.8% in the 2nd quarter. Cetera Advisors LLC now owns 23,669 shares of the company’s stock worth $67,000 after purchasing an additional 8,277 shares in the last quarter. Institutional investors and hedge funds own 11.94% of the company’s stock.

Cronos Group Trading Down 1.5 %

Shares of NASDAQ:CRON opened at $1.93 on Monday. Cronos Group Inc. has a 1-year low of $1.90 and a 1-year high of $4.31. The stock has a market cap of $734.52 million, a PE ratio of -4.29 and a beta of 1.53. The stock’s fifty day simple moving average is $2.35 and its two-hundred day simple moving average is $2.74.

Wall Street Analyst Weigh In

Separately, Raymond James cut their target price on Cronos Group from $7.00 to $3.00 and set an “outperform” rating on the stock in a report on Wednesday, March 1st. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Cronos Group presently has an average rating of “Moderate Buy” and a consensus target price of $3.56.

Insider Activity

In other Cronos Group news, Director Jason Marc Adler bought 94,600 shares of the firm’s stock in a transaction dated Wednesday, December 14th. The stock was purchased at an average cost of $2.83 per share, with a total value of $267,718.00. Following the transaction, the director now directly owns 973,277 shares in the company, valued at approximately $2,754,373.91. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 5.95% of the company’s stock.

About Cronos Group

(Get Rating)

Cronos Group, Inc engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.